139 related articles for article (PubMed ID: 27659267)
1. Current biomarkers of invasive sporadic pituitary adenomas.
Zheng X; Li S; Zhang W; Zang Z; Hu J; Yang H
Ann Endocrinol (Paris); 2016 Dec; 77(6):658-667. PubMed ID: 27659267
[TBL] [Abstract][Full Text] [Related]
2. Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review.
de Aguiar PH; Aires R; Laws ER; Isolan GR; Logullo A; Patil C; Katznelson L
Neurol Res; 2010 Dec; 32(10):1060-71. PubMed ID: 20483025
[TBL] [Abstract][Full Text] [Related]
3. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
4. O-6-Methylguanine-DNA methyltransferase expression is associated with pituitary adenoma tumor recurrence: a systematic meta-analysis.
Dai C; Sun B; Liu X; Bao X; Feng M; Yao Y; Wei J; Deng K; Yang C; Li X; Ma W; Wang R
Oncotarget; 2017 Mar; 8(12):19674-19683. PubMed ID: 28152515
[TBL] [Abstract][Full Text] [Related]
5. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
[TBL] [Abstract][Full Text] [Related]
6. Pituitary tumors: prognostic indicators.
Saeger W
Endocrine; 2005 Oct; 28(1):57-66. PubMed ID: 16311411
[TBL] [Abstract][Full Text] [Related]
7. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification.
Micko AS; Wöhrer A; Wolfsberger S; Knosp E
J Neurosurg; 2015 Apr; 122(4):803-11. PubMed ID: 25658782
[TBL] [Abstract][Full Text] [Related]
8. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of soluble CD44v6 in peripheral blood as assistant diagnosis of invasive pituitary adenomas].
Kong YG; Su CB; Ren ZY; Wang RZ; Li GL; Dou WC; Zhang B; Tian SQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):698-701. PubMed ID: 14714315
[TBL] [Abstract][Full Text] [Related]
10. Invasive pituitary adenomas: significance of proliferation parameters.
Amar AP; Hinton DR; Krieger MD; Weiss MH
Pituitary; 1999 Aug; 2(2):117-22. PubMed ID: 11081161
[TBL] [Abstract][Full Text] [Related]
11. [Hypophyseal adenomas with invasive growth].
Patsko IaV; Shamaev MI; Rasheeva IG
Zh Vopr Neirokhir Im N N Burdenko; 1989; (5):16-8. PubMed ID: 2596224
[No Abstract] [Full Text] [Related]
12. [Differential expression of DJ-1 and HSP27 in invasive and non-invasive pituitary adenomas].
Chen W; Shi X; Liu Y; Li C; Xiao Z; Liu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 May; 37(5):481-4. PubMed ID: 22659660
[TBL] [Abstract][Full Text] [Related]
13. Computational analysis identifies invasion-associated genes in pituitary adenomas.
Cao C; Wang W; Ma C; Jiang P
Mol Med Rep; 2015 Aug; 12(2):1977-82. PubMed ID: 25824863
[TBL] [Abstract][Full Text] [Related]
14. Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma.
Kong YG; Ren ZY; Su CB; Wang RZ; Ma WB; Lian W
Chin Med Sci J; 2004 Sep; 19(3):199-202. PubMed ID: 15506648
[TBL] [Abstract][Full Text] [Related]
15. Invasiveness of pituitary adenomas.
Sautner D; Saeger W
Pathol Res Pract; 1991 Jun; 187(5):632-6. PubMed ID: 1923959
[TBL] [Abstract][Full Text] [Related]
16. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
17. Pituitary Adenoma in Pediatric and Adolescent Populations.
Chen J; Schmidt RE; Dahiya S
J Neuropathol Exp Neurol; 2019 Jul; 78(7):626-632. PubMed ID: 31115468
[TBL] [Abstract][Full Text] [Related]
18. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
19. Treatment of intracavernous extensions of pituitary adenomas.
MacKay A; Hosobuchi Y
Surg Neurol; 1978 Dec; 10(6):377-83. PubMed ID: 741360
[TBL] [Abstract][Full Text] [Related]
20. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]